Utility of Antimicrobial Susceptibility Testing in Trichomonas vaginalis–Infected Women With Clinical Treatment Failure

Background:Antimicrobial resistance is one of the causes of treatment failure in women after standard nitroimidazole therapy for Trichomonas vaginalis infections. The Centers for Disease Control and Prevention provides drug susceptibility testing and guidance for treatment failures but the efficacy